CIK: 0001538653 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 14, 2019
Total Value ($000): $2,548,010 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 2,116,840 | $976,519 | 38.3% | $107.75 | +338.5% | COM | 225310101 |
| — | CIMPRESS N V | 4,656,492 | $613,912 | 24.1% | $74.93 | — | SHS EURO | N20146101 |
| W | WAYFAIR INC | 3,516,606 | $394,282 | 15.5% | $46.74 | +173.8% | CL A | 94419L101 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $259,801 | 10.2% | $81.92 | +72.7% | COM | 981419104 |
| YELP | YELP INC | 4,956,026 | $172,222 | 6.8% | $30.71 | +12.6% | CL A | 985817105 |
| NUS | NU SKIN ENTERPRISES INC | 1,142,959 | $48,610 | 1.9% | $47.91 | -30.4% | CL A | 67018T105 |
| — | SYSTEMAX INC | 2,111,944 | $46,484 | 1.8% | $9.46 | — | COM | 871851101 |
| BFH | ALLIANCE DATA SYSTEMS CORP | 265,370 | $34,002 | 1.3% | $118.19 | -15.1% | COM | 018581108 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 1,851,851 | $1,815 | 0.1% | $1.03 | 0.0% | COM | 53566P109 |
| — | AGEX THEREPEUTICS INC | 185,185 | $363 | 0.0% | $2.99 | — | COM | 00848H108 |